EyePoint, Inc. Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value
EyePoint, Inc. (EYPT) reported Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value of $2.29 per share for the 3-month period ending 2016-09-30, per its 10-Q filed 2016-11-08.
Discontinued › Notes › Compensation Related Costs › Share-Based Payment Arrangement, Disclosure
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue · last filed 2016-11-08
- EyePoint, Inc. share-based compensation arrangement by share-based payment award, options, grants in period, weighted average grant date fair value for the quarter ending 2016-09-30 was $2.29, a 20.21% decline year-over-year.
- EyePoint, Inc. share-based compensation arrangement by share-based payment award, options, grants in period, weighted average grant date fair value for the quarter ending 2015-09-30 was $2.87, a 16.57% decline year-over-year.
- EyePoint, Inc. share-based compensation arrangement by share-based payment award, options, grants in period, weighted average grant date fair value for the quarter ending 2014-09-30 was $3.44, a 26.94% increase year-over-year.
- EyePoint, Inc. share-based compensation arrangement by share-based payment award, options, grants in period, weighted average grant date fair value for the quarter ending 2013-09-30 was $2.71, a 64.24% increase year-over-year.
- EyePoint, Inc. share-based compensation arrangement by share-based payment award, options, grants in period, weighted average grant date fair value for fiscal 2016 was $2.74, a 17.72% decline from fiscal 2015.
- EyePoint, Inc. share-based compensation arrangement by share-based payment award, options, grants in period, weighted average grant date fair value for fiscal 2015 was $3.33, a 34.27% increase from fiscal 2014.
- EyePoint, Inc. share-based compensation arrangement by share-based payment award, options, grants in period, weighted average grant date fair value for fiscal 2014 was $2.48, a 92.25% increase from fiscal 2013.
- EyePoint, Inc. share-based compensation arrangement by share-based payment award, options, grants in period, weighted average grant date fair value for fiscal 2013 was $1.29, a 46.47% decline from fiscal 2012.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value 6 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value 9 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value 12 month |
|---|---|---|---|---|
| 2016-09-30 | $2.29 10-Q · filed 2016-11-08 | |||
| 2016-06-30 | $2.74 10-K · filed 2016-09-13 | |||
| 2016-03-31 | $2.74 10-Q · filed 2016-05-06 | |||
| 2015-12-31 | $2.74 10-Q · filed 2016-02-09 | |||
| 2015-09-30 | $2.87 10-Q · filed 2015-11-06 | |||
| 2015-06-30 | $3.33 10-K · filed 2016-09-13 | |||
| 2015-03-31 | $3.33 10-Q · filed 2015-05-08 | |||
| 2014-12-31 | $3.33 10-Q · filed 2015-02-06 | |||
| 2014-09-30 | $3.44 10-Q · filed 2014-11-07 | |||
| 2014-06-30 | $2.48 10-K · filed 2016-09-13 | |||
| 2014-03-31 | $2.48 10-Q · filed 2014-05-14 | |||
| 2013-09-30 | $2.71 10-Q · filed 2013-11-13 | |||
| 2013-06-30 | $1.29 10-K · filed 2015-09-10 | |||
| 2013-03-31 | $1.29 10-Q · filed 2013-05-14 | |||
| 2012-12-31 | $1.29 10-Q · filed 2013-02-08 | |||
| 2012-09-30 | $1.65 10-Q · filed 2012-11-09 | |||
| 2012-06-30 | $2.41 10-K · filed 2014-09-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| 908 Devices Inc. (MASS) | United States | $0.476B | -9.53 |
| Quanterix Corp (QTRX) | United States | $0.150B | -1.65 |
| PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB) | United States | $0.491B | -3.95 |
| Nautilus Biotechnology, Inc. (NAUT) | United States | $0.129B | -4.16 |
| Seer, Inc. (SEER) | United States | $0.104B | -1.34 |
| Precipio, Inc. (PRPO) | United States | $0.043B | -36.70 |
| HARVARD BIOSCIENCE INC (HBIO) | United States | $0.037B | -2.70 |
| Bionano Genomics, Inc. (BNGO) | United States | $0.020B | -0.42 |
| ASTROTECH Corp (ASTC) | United States | $0.013B | |
| Cytek Biosciences, Inc. (CTKB) | United States | $0.744B | -7.15 |